Ledger.Open graph →
SEC Form D · filed December 30, 2014

Oncolinx Pharmaceuticals, LLC

Offering
$1.0M
Sold
$350K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Riley Ennis · Boston, MAExec · Director · PromoterSourav Sinha · Boston, MAExec · Director · PromoterRiley Ennis · Boston, MAExec · Director · PromoterSourav Sinha · Boston, MAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗